Acute chest pain, a common yet perplexing clinical presentation, often poses diagnostic challenges for healthcare professionals. The differential diagnosis is broad, ranging from benign musculoskeletal causes to life-threatening conditions such as myocardial infarction. This article provides a comprehensive approach to evaluating and managing patients presenting with acute chest pain.
Initial evaluation should involve a detailed history and physical examination. Key elements include the character, onset, location, duration, associated symptoms, and any exacerbating or relieving factors. Concurrently, vital signs and electrocardiogram (ECG) should be obtained promptly to identify any immediate life-threatening conditions.
Further diagnostic evaluation depends on the initial clinical assessment. For patients with suspected cardiac chest pain, serial cardiac biomarkers and a stress test may be indicated. In cases of suspected pulmonary embolism or aortic dissection, computed tomography angiography (CTA) may be required. For patients with a low pretest probability of cardiac etiology, alternative diagnoses such as gastroesophageal reflux disease or musculoskeletal pain should be considered.
Management depends on the underlying cause of chest pain. Patients with acute coronary syndrome require prompt revascularization, while those with pulmonary embolism may require anticoagulation. It is also essential to address modifiable risk factors and provide appropriate counseling to patients.
Acute chest pain is a complex clinical entity that requires a systematic approach for effective evaluation and management. By tailoring the diagnostic workup based on initial assessment and considering a broad differential diagnosis, healthcare professionals can ensure optimal patient outcomes. Continued education and clinical vigilance are key in this constantly evolving field.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation